Sera Prognostics Receives New York State Approval for PreTRM® Testing
12 déc. 2018 08h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that the New York State Department of Health has issued a clinical laboratory...
Sera Prognostics Completes Enrollment of Large, Multicenter, Prospective Clinical Study of PreTRM® Test
27 nov. 2018 08h00 HE
|
Sera Prognostics, Inc.
TREETOP Study will Explore Enhancements to Sera’s Validated PreTRM® Test SALT LAKE CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that...
Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
21 juin 2018 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that Garrett K. Lam, M.D., FACOG, will be joining the company as chief medical...
Sera Prognostics Collaborates with Christiana Care Health System to Launch New Preterm Birth Study with PreTRM® Test
19 juin 2018 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 19, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s health company, announced today that the first patient has been enrolled in the AVERT PRETERM TRIAL. This is the second...
Key Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in Biotechnology
12 févr. 2018 08h00 HE
|
Sera Prognostics, Inc.
SEATTLE and SALT LAKE CITY, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s health company, in collaboration with The Institute for Systems Biology and Integrated Diagnostics (Indi),...
Sera Prognostics to Present at the 11th Annual Canaccord Genuity Medical Technologies and Diagnostics Forum
06 nov. 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at the Baird 2017 Global Healthcare Conference
05 sept. 2017 10h49 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Sera Prognostics Receives Accreditation from College of American Pathologists
29 juin 2017 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 29, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that the Accreditation Committee of the College of American Pathologists (CAP)...
Sera Prognostics Announces Analytical Validation Study Published in Clinical Mass Spectrometry
26 juin 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 26, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that its recent analytical study, Analytical Validation of Protein Biomarkers...
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
17 mai 2017 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, May 17, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that Nadia F. Altomare has joined the company as chief commercial officer....